Apoptosis signal-regulating kinase 1 deficiency attenuates vascular injury-induced neointimal hyperplasia by suppressing apoptosis in smooth muscle cells

Am J Pathol. 2013 Feb;182(2):597-609. doi: 10.1016/j.ajpath.2012.10.008. Epub 2012 Nov 22.

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase that plays a crucial role in stress-induced apoptosis. Recently, we have reported that suppressed macrophage apoptosis in ASK1 and apolipoprotein E double-knockout mice accelerates atheromatous plaques in the hyperlipidemia-induced atherosclerotic model. However, the pathogenic role of smooth muscle cell (SMC) apoptosis in atherosclerosis still remains unclear. We investigated neointimal remodeling in ligated carotid arteries of ASK1-deficient mice (ASK1(-/-)) for 3 weeks. ASK1(-/-) mice had significantly more suppressed intimal formation, inversely manifesting as potential anti-atherogenic aspects of ASK1 deficiency, characterized by fewer SMCs and less collagen synthesis; and fewer apoptotic SMCs, infiltrating T lymphocytes, and microvessels, associated with decreased apoptosis of luminal endothelial cells, compared with those of wild-type mice. Injured arteries of ASK1(-/-) mice also showed significantly down-regulated expression of pro-apoptotic markers, adhesion molecules, and pro-inflammatory signaling factors. Moreover, tumor necrosis factor-α-induced apoptosis was markedly suppressed in cultured aortic SMCs from ASK1(-/-) mice. These findings suggest that ASK1 accelerates mechanical injury-induced vascular remodeling with activated SMC migration via increased neovascularization and/or enhanced SMC and endothelial cell apoptosis. ASK1 expression, especially in the SMCs, might be crucial, and reciprocally responsible for various pro-atherogenic functions, and SMC apoptosis seems to be detrimental in this model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / enzymology
  • Aorta / pathology
  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Becaplermin
  • Carotid Arteries / drug effects
  • Carotid Arteries / enzymology*
  • Carotid Arteries / pathology*
  • Cell Adhesion Molecules / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Gene Expression Regulation / drug effects
  • Hyperplasia
  • Immunohistochemistry
  • Inflammation / genetics
  • Inflammation / pathology
  • Ligation
  • MAP Kinase Kinase Kinase 5 / deficiency*
  • MAP Kinase Kinase Kinase 5 / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / enzymology
  • Myocytes, Smooth Muscle / pathology*
  • Neointima / enzymology*
  • Neointima / pathology*
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-sis / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Stress, Physiological / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Cell Adhesion Molecules
  • Proto-Oncogene Proteins c-sis
  • Tumor Necrosis Factor-alpha
  • Becaplermin
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 5
  • Map3k5 protein, mouse